Expertise in
2
conditions

Olivier Chapet

CHU De Lyon Sud
Lyon, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
2
conditions
CHU De Lyon Sud
Lyon, FR 
OverviewLocationsClinical Research

Overview

Olivier Chapet practices in Lyon, France. Mr. Chapet is highly rated in 2 conditions, according to our data. His top areas of expertise are Prostate Cancer, Erectile Dysfunction (ED), Colorectal Cancer, Prostatectomy, and Nephrectomy.

His clinical research consists of co-authoring 68 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

CHU de Lyon Sud
Lyon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Erectile Dysfunction in Good Prognosis Prostate Cancer: a Phase III Medico-economic Study Comparing Brachytherapy to Stereotactic Body Radiotherapy
Erectile Dysfunction in Good Prognosis Prostate Cancer: a Phase III Medico-economic Study Comparing Brachytherapy to Stereotactic Body Radiotherapy
Enrollment Status: Recruiting
Publish Date: August 01, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
European Phase III Study Comparing a Radiation Dose Escalation Using 2 Different Approaches : External Beam Radiation Therapy Versus Endocavitary Radiation Therapy With Contact X-ray Brachytherapy 50 kiloVolts (kV) for Patients With Rectal Adenocarcinoma
European Phase III Study Comparing a Radiation Dose Escalation Using 2 Different Approaches : External Beam Radiation Therapy Versus Endocavitary Radiation Therapy With Contact X-ray Brachytherapy 50 kiloVolts (kV) for Patients With Rectal Adenocarcinoma
Enrollment Status: Active_not_recruiting
Publish Date: September 29, 2025
Intervention Type: Device, Drug, Radiation
Study Phase: Phase 3
Impact of Solifenacin Succinate for Treatment of Acute Irritative Urinary Toxicity Occurring During Radiotherapy of Prostatic Cancer
Impact of Solifenacin Succinate for Treatment of Acute Irritative Urinary Toxicity Occurring During Radiotherapy of Prostatic Cancer
Enrollment Status: Terminated
Publish Date: January 19, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trial

68 Total Publications

Updated 2025 French Guidelines for Renal Cell Carcinoma.
Updated 2025 French Guidelines for Renal Cell Carcinoma.
Journal: The French journal of urology
Published: October 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Chapet's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile